178 related articles for article (PubMed ID: 37102780)
1. Effect of Nebulized BromAc on Rheology of Artificial Sputum: Relevance to Muco-Obstructive Respiratory Diseases.
Pillai K; Mekkawy AH; Akhter J; Morris DL
Adv Respir Med; 2023 Apr; 91(2):146-163. PubMed ID: 37102780
[TBL] [Abstract][Full Text] [Related]
2. Ex-vivo mucolytic and anti-inflammatory activity of BromAc in tracheal aspirates from COVID-19.
Coelho Dos Reis JGA; Ferreira GM; Lourenço AA; Ribeiro ÁL; da Mata CPDSM; de Melo Oliveira P; Marques DPA; Ferreira LL; Clarindo FA; da Silva MF; Filho HPP; Oliveira NRR; Sodré MMD; Gadelha SR; Albuquerque GR; Maciel BM; Mariano APM; Silva MM; Fontana R; Marin LJ; Carlos RSA; Lopes ATS; Ferreira FB; Dos Santos UR; Santana ÍTS; Fehlberg HF; Rezende RP; Dias JCT; Gross E; Goulart GAC; Santiago MG; de Lemos APML; da Conceição AO; Romano CC; de Carvalho LD; Martins Filho OA; Quadros CA; Morris DL; Valle SJ
Biomed Pharmacother; 2022 Apr; 148():112753. PubMed ID: 35272139
[TBL] [Abstract][Full Text] [Related]
3. A novel treatment of bromelain and acetylcysteine (BromAc) in patients with peritoneal mucinous tumours: A phase I first in man study.
Valle SJ; Akhter J; Mekkawy AH; Lodh S; Pillai K; Badar S; Glenn D; Power M; Liauw W; Morris DL
Eur J Surg Oncol; 2021 Jan; 47(1):115-122. PubMed ID: 31679953
[TBL] [Abstract][Full Text] [Related]
4. The Combination of Bromelain and Acetylcysteine (BromAc) Synergistically Inactivates SARS-CoV-2.
Akhter J; Quéromès G; Pillai K; Kepenekian V; Badar S; Mekkawy AH; Frobert E; Valle SJ; Morris DL
Viruses; 2021 Mar; 13(3):. PubMed ID: 33800932
[TBL] [Abstract][Full Text] [Related]
5. An Improved Inhaled Mucolytic to Treat Airway Muco-obstructive Diseases.
Ehre C; Rushton ZL; Wang B; Hothem LN; Morrison CB; Fontana NC; Markovetz MR; Delion MF; Kato T; Villalon D; Thelin WR; Esther CR; Hill DB; Grubb BR; Livraghi-Butrico A; Donaldson SH; Boucher RC
Am J Respir Crit Care Med; 2019 Jan; 199(2):171-180. PubMed ID: 30212240
[TBL] [Abstract][Full Text] [Related]
6. A novel thiol-saccharide mucolytic for the treatment of muco-obstructive lung diseases.
Addante A; Raymond W; Gitlin I; Charbit A; Orain X; Scheffler AW; Kuppe A; Duerr J; Daniltchenko M; Drescher M; Graeber SY; Healy AM; Oscarson S; Fahy JV; Mall MA
Eur Respir J; 2023 May; 61(5):. PubMed ID: 37080569
[TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal BromAc
Mekkawy AH; Breakeit M; Pillai K; Badar S; Akhter J; Valle SJ; Morris DL
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444430
[TBL] [Abstract][Full Text] [Related]
8. Impact of PEGylation on the mucolytic activity of recombinant human deoxyribonuclease I in cystic fibrosis sputum.
Guichard MJ; Kinoo D; Aubriot AS; Bauwens N; Gougué J; Vermeulen F; Lebecque P; Leal T; Vanbever R
Clin Sci (Lond); 2018 Jul; 132(13):1439-1452. PubMed ID: 29871879
[TBL] [Abstract][Full Text] [Related]
9. Bromelain and acetylcysteine (BromAc
Mekkawy AH; Pillai K; Suh H; Badar S; Akhter J; Képénékian V; Ke K; Valle SJ; Morris DL
Am J Transl Res; 2021; 13(12):13524-13539. PubMed ID: 35035694
[TBL] [Abstract][Full Text] [Related]
10. Bromelain and acetylcysteine (BromAc
Wen HK; Valle SJ; Morris DL
Am J Cancer Res; 2023; 13(4):1522-1532. PubMed ID: 37168359
[TBL] [Abstract][Full Text] [Related]
11. N-acetylcysteine enhances cystic fibrosis sputum penetration and airway gene transfer by highly compacted DNA nanoparticles.
Suk JS; Boylan NJ; Trehan K; Tang BC; Schneider CS; Lin JM; Boyle MP; Zeitlin PL; Lai SK; Cooper MJ; Hanes J
Mol Ther; 2011 Nov; 19(11):1981-9. PubMed ID: 21829177
[TBL] [Abstract][Full Text] [Related]
12. A formulation for in situ lysis of mucin secreted in pseudomyxoma peritonei.
Pillai K; Akhter J; Chua TC; Morris DL
Int J Cancer; 2014 Jan; 134(2):478-86. PubMed ID: 23843173
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacological effects of N-acetyl-L-cysteine on the respiratory tract. (I). Quantitative and qualitative changes in respiratory tract fluid and sputum (author's transl)].
Kogi K; Saito T; Kasé Y; Hitoshi T
Nihon Yakurigaku Zasshi; 1981 Jun; 77(6):569-78. PubMed ID: 7286849
[TBL] [Abstract][Full Text] [Related]
14. Rheological assessment of mucolytic agents on sputum of chronic bronchitics.
Dippy JE; Davis SS
Thorax; 1969 Nov; 24(6):707-13. PubMed ID: 5350721
[No Abstract] [Full Text] [Related]
15. A novel method for potentiation of chemotherapy in soft tissue sarcomas with BromAc.
Dong L; Ke K; Badar S; Mekkawy AH; Akhter J; Pillai K; Carter CJ; Morris DL
Am J Transl Res; 2022; 14(5):2894-2909. PubMed ID: 35702130
[TBL] [Abstract][Full Text] [Related]
16. Apparent Yield Stress of Sputum as a Relevant Biomarker in Cystic Fibrosis.
Ghanem R; Roquefort P; Ramel S; Laurent V; Haute T; Le Gall T; Aubry T; Montier T
Cells; 2021 Nov; 10(11):. PubMed ID: 34831330
[TBL] [Abstract][Full Text] [Related]
17. Reduction in viscoelasticity in cystic fibrosis sputum in vitro using combined treatment with nacystelyn and rhDNase.
Dasgupta B; King M
Pediatr Pulmonol; 1996 Sep; 22(3):161-6. PubMed ID: 8893254
[TBL] [Abstract][Full Text] [Related]
18. Taming the SARS-CoV-2-mediated proinflammatory response with BromAc
Ferreira GM; Clarindo FA; Ribeiro ÁL; Gomes-de-Pontes L; de Carvalho LD; Martins-Filho OA; da Fonseca FG; Teixeira MM; Sabino AP; Eapen MS; Morris DL; Valle SJ; Coelho-Dos-Reis JGA
Front Immunol; 2023; 14():1308477. PubMed ID: 38193087
[TBL] [Abstract][Full Text] [Related]
19. Novel Use of Bromelain and Acetylcysteine (BromAc®) for Pleural Involvement in Pseudomyxoma Peritonei.
Lam AR; Bazzi K; Valle SJ; Morris DL
Case Rep Oncol; 2021; 14(1):628-633. PubMed ID: 33976645
[TBL] [Abstract][Full Text] [Related]
20. Addition of bromelain and acetylcysteine to gemcitabine potentiates tumor inhibition
Mekkawy AH; Pillai K; Badar S; Akhter J; Ke K; Valle SJ; Morris DL
Am J Cancer Res; 2021; 11(5):2252-2263. PubMed ID: 34094682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
